Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
An open label, single site, 12 month, Phase II, randomised controlled trial evaluating the safety and efficacy of Exendin-4 (Exenatide) in the treatment of patients with moderate severity Parkinson's disease.
Primary Objective- To collect pilot data from which to estimate the effectiveness of Exenatide in modifying the progression of the motor symptoms of patients with moderate severity of Parkinson’s disease, using a validated scale -the UPDRS off medication motor score as the main primary outcome measure.
2 Researchers
-
Clinical and Movement Neurosciences
-
extResource/image/01/TFOLT83Clinical and Movement Neurosciences
› More search options
Status:
Active
